NCT01435707

Brief Summary

There has been no reports of the effect of various kinds of steroid or various dose of steroid which are commonly used in the clinical setting. Previous studies have simply shown that the blood glucose level is elevated in diabetes patients and did not show or suggest the adequate strategy of epidural steroid injection in diabetes patients regarding steroid type, dosage or injection interval. Therefore, the investigators tried to evaluate the effect of different dosage of triamcinolone, which is a commonly used steroid in epidural steroid injection, on the blood glucose level.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
125

participants targeted

Target at P75+ for not_applicable low-back-pain

Timeline
Completed

Started Sep 2011

Typical duration for not_applicable low-back-pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2011

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

September 15, 2011

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 19, 2011

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2013

Completed
Last Updated

December 25, 2013

Status Verified

December 1, 2013

Enrollment Period

1.5 years

First QC Date

September 15, 2011

Last Update Submit

December 24, 2013

Conditions

Keywords

epidural steroid injectiontriamcinolonefasting blood glucosediabetes mellitus

Outcome Measures

Primary Outcomes (8)

  • fasting blood glucose level

    before breakfast (fasting state)

    at 7:00 am of postprocedure day 1

  • fasting blood glucose level

    before breakfast (fasting state)

    at 7:00 am of postprocedure day 2

  • fasting blood glucose level

    at 7:00 am of postprocedure day 3

  • fasting blood glucose level

    at 7:00 am of postprocedure day 4

  • fasting blood glucose level

    at 7:00 am of postprocedure day 5

  • fasting blood glucose level

    at 7:00 am of postprocedure day 6

  • fasting blood glucose level

    at 7:00 am of postprocedure day 7

  • fasting blood glucose

    at 7:00 am of postprocedure day 14

Secondary Outcomes (2)

  • post-prandial glucose level

    2 hour after dinner at postprandial day 1, 2, 3, 4, 5, 6, 7, 14

  • visual analogue scale of subjective pain

    at 7 p.m. of postprocedure day 1, 2, 3, 4, 5, 6, 7, 14

Study Arms (4)

Caudal 40 group

EXPERIMENTAL

subjects who undergo caudal epidural block with triamcinolone 40 mg

Other: epidural steroid injection with Triamcinolone 40mg

STE 20 group

EXPERIMENTAL

subjects who undergo selective transforaminal block with triamcinolone 20 mg

Other: Selective transforaminal epidural block with triamcinolone 20 mg

Caudal 20 mg

EXPERIMENTAL

subjects who undergo caudal epidural block with triamcinolone 20 mg

Other: caudal epidural steroid injection with Triamcinolone 20mg

STE 40 group

EXPERIMENTAL

subjects who undergo selective transforaminal block with triamcinolone 40 mg

Other: Selective transforaminal epidural block with triamcinolone 40 mg

Interventions

epidural steroid injection with Triamcinolone 40mg

Also known as: Triamcinolone, epidural steroid injection, caudal epidural block
Caudal 40 group

Selective transforaminal epidural block with triamcinolone 20 mg

Also known as: selective transforaminal block, Triamcinolone, epidural steroid injection
STE 20 group

caudal epidural steroid injection with Triamcinolone 20mg

Also known as: Triamcinolone, epidural steroid injection, caudal epidural block
Caudal 20 mg

Selective transforaminal epidural block with triamcinolone 40 mg

Also known as: selective transforaminal block, Triamcinolone, epidural steroid injection
STE 40 group

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • subjects who undergo epidural steroid injection (caudal epidural injection or selective transforaminal block) in the pain medicine outpatient clinic
  • subjects older than 20 yrs.

You may not qualify if:

  • ASA (American society of Anesthesiologists class) III or more
  • severe cardiopulmonary disease or brain disorder
  • Subjects diagnosed uncontrolled diabetes with complications
  • subjects undergoing hormone therapy
  • subjects with active infection
  • subjects with pregnancy
  • subjects with recent stress condition such as surgery or trauma
  • subjects with active neurologic disorder
  • those with anticoagulation therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Samsung Medical Center

Seoul, 135-710, South Korea

Location

Related Publications (1)

  • Kim WH, Sim WS, Shin BS, Lee CJ, Jin HS, Lee JY, Roe HJ, Kim CS, Lee SM. Effects of two different doses of epidural steroid on blood glucose levels and pain control in patients with diabetes mellitus. Pain Physician. 2013 Nov-Dec;16(6):557-68.

MeSH Terms

Conditions

Low Back PainDiabetes Mellitus

Interventions

Triamcinolone

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

PregnadienesPregnanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSteroids, Fluorinated

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

September 15, 2011

First Posted

September 19, 2011

Study Start

September 1, 2011

Primary Completion

March 1, 2013

Study Completion

March 1, 2013

Last Updated

December 25, 2013

Record last verified: 2013-12

Locations